View in EDS PDF Full Text

Oral ganciclovir versus valganciclovir for cytomegalovirus prophylaxis in high-risk liver transplant recipients.

Saved in:
Bibliographic Details
Title: Oral ganciclovir versus valganciclovir for cytomegalovirus prophylaxis in high-risk liver transplant recipients.
Authors: Brady, R. L.1, Green, K.1, Frei, C.2, Maxwell, P.1 pamela.maxwell@uhs-sa.com
Source: Transplant Infectious Disease. Apr2009, Vol. 11 Issue 2, p106-111. 6p. 4 Charts.
Database: Academic Search Ultimate
Description
ISSN:13982273
DOI:10.1111/j.1399-3062.2008.00356.x